Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells

Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells

Cisplatin (cis-diamminedichloroplatinum) is widely used for the treatment of solid malignancies; however, the development of chemoresistance hinders the success of this chemotherapeutic in the clinic. This study provides novel insights into the molecular and phenotypic changes in an isogenic oesopha...

Full description

Bibliographic Details
Main Authors: Amy M. Buckley, Becky AS. Bibby, Margaret R. Dunne, Susan A. Kennedy, Maria B. Davern, Breandán N. Kennedy, Stephen G. Maher, Jacintha O’Sullivan
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Pharmaceuticals
Subjects:
oesophageal cancer
treatment resistance
cisplatin
metabolism
inflammation
radiation
Online Access:https://www.mdpi.com/1424-8247/12/1/33

Internet

https://www.mdpi.com/1424-8247/12/1/33

Similar Items